C-mo Medical Solutions
C-mo enables sponsors to objectively measure subtle changes in a patient’s cough characteristics throughout a study, capturing early treatment effects and key safety signals. Our AI-powered wearable biosensor delivers privacy-preserving data on cough frequency, intensity, and patterns, producing endpoints that go well beyond traditional lung function metrics in IPF and ILD drug development.
